Last Posted: Jan 16, 2020
- BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling.
Chao Angel et al. Journal of gynecologic oncology 2019 Oct - Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Woodward Wendy A et al. JAMA oncology 2020 Jan - Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors.
Ryu Jai Min et al. Japanese journal of clinical oncology 2020 Jan - Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study.
Liu Kai-Hua et al. Breast (Edinburgh, Scotland) 2019 Dec 49233-241 - The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.
Conley Claire C et al. Journal of genetic counseling 2020 Jan - Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.
Doe Samfee et al. The breast journal 2020 Jan - Stand-alone artificial intelligence - The future of breast cancer screening?
Sechopoulos Ioannis et al. Breast (Edinburgh, Scotland) 2020 Jan 49254-260 - Characteristics and outcome of AKT1 E17K-mutant breast cancer defined through AACR GENIE, a clinicogenomic registry.
Smyth Lillian M et al. Cancer discovery 2020 Jan - Comparison of clinical features and oncologic outcomes between familial (non-hereditary) and hereditary breast cancer in Korean female patients.
Park Chan Sub et al. Asian journal of surgery 2020 Jan - OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
Yan Zhongyi et al. Frontiers in oncology 2019 91349
.png)
No hay comentarios:
Publicar un comentario